Refine by
Cytology Articles & Analysis: Older
22 articles found
Alfa Cytology has unveiled new services focused on therapeutic antibody development for bladder cancer research.Alfa Cytology, a prominent cancer research services supplier based in New York, proudly announces the launch of its comprehensive services for bladder cancer therapeutic antibody development. ...
Breast cancer remains one of the most prevalent malignancies affecting women worldwide, necessitating innovative approaches for effective treatment and research. Among the most promising strategies in this endeavor are the use of tumor models for breast cancer and the development of customized antibody-drug conjugates (ADCs). These advancements not only enhance our understanding of the disease ...
Alfa Cytology has introduced its advanced drug development services for brain tumors. ...
Alfa Cytology has announced cancer diagnostic biomarker development services to enhance precision in oncology research. ...
Peptidomimetics are structural analogs of peptides or proteins that mimic their biological activities. They are designed to overcome limitations associated with peptides, such as poor stability and bioavailability by preserving or enhancing their functions. Peptidomimetic development involves the design and synthesis of molecules that mimic three-dimensional structures and functional groups of ...
Whether pathologic research or therapeutics development, CD BioSciences practically has experienced cytology experts with advanced equipment and tech to accelerate research progress. ...
Brain tumors can be broadly categorized into primary and secondary (or metastatic) tumors. Primary tumors originate in the brain1, while secondary tumors spread from other body parts. Treatment options traditionally include surgery, radiation therapy, and chemotherapy. However, these approaches can be invasive and have severe side effects. The battle against brain tumors is being ...
Cancer is a daunting diagnosis; however, the rapid advancements in oncology are continuously perfecting patient outcomes and quality of life. Among the groundbreaking developments, cancer vaccines are a promising frontier1. These vaccines are transforming how we approach cancer treatment, leveraging the body's immune system to fight malignancies more effectively. To grasp how cancer vaccines ...
Alfa Cytology has announced pancreatic cancer vaccine development services to improve the efficacy and safety of related vaccines. ...
Breast cancer is a type of cancer that begins in the cells of the breast. It can occur in both men and women but is more common in women. Breast cancer can develop in different parts of the breast, including the tubes that carry milk to the nipple or the lobules that produce milk. The exact cause of breast cancer is not completely understood, but factors such as genetics, hormone situations, ...
Alfa Cytology has announced its small molecule drug development to advance preclinical cancer research. ...
Alfa Cytology has announced tumor models customization service for pancreatic cancer research. ...
In addition, several contract research organizations (e.g., Alfa Cytology) are exploring small molecule drug development for the treatment of brain tumors. ...
The development of monoclonal antibodies (mAbs) has completely transformed the field of medicine, providing targeted antidotes against a wide range of diseases, including cancer, autoimmune and infectious diseases. These therapeutic antibodies aim to specifically target antigens on the surface of cells and bind to them, leading to acidic reactions that result in the destruction of target cells. ...
X-ZELL is collaborating with one of Germany’s leading cytopathology centres to introduce Cryoimmunostaining™ into routine cytology as a tool to efficiently analyse lung fluids such as bronchoalveolar lavage and pleural effusion and enable near-instant diagnoses through digital on-screen analysis. ...
Since the 19th century, the practice of tissue processing has remained largely unchanged, resulting in solidified, paraffin-embedded tissue blocks for sectioning. As staining procedures have advanced and immunohistochemistry is becoming more widely used, high-quality tissue sections are paramount for accurate interpretation of disease ...
Currently, bladder cancers are diagnosed using cystoscopy, the gold standard procedure for bladder cancer screening, and monitored with urine cytology tests. Cystoscopy is invasive, uncomfortable, and has limited detection capacity for some forms of bladder cancer. ...
SNP Array in Clinical Diagnosis Accurate identification and definition of genome aberrations can influence classifications of disease, patient risk stratification and clinical management options for a variety of genetic diseases, such as tumors. Traditional cytological genetic methods are standard methods for genome-wide assessment prior to methods such as karyotyping, among ...
The digital pathology software company PathPresenter (Montville, New Jersey) and the precision oncology platform firm 4D Path have entered into a partnership that could improve the diagnostic accuracy of breast tumor profiling. PathPresenter has developed a digital workflow tool for clinicians, pathologists and pharma companies to aggregate medical data. ...
The Non-Intrusive LuCED Test for Detection of Early-Stage Lung Cancer: A Subgroup Analysis for Chronic Obstructive Pulmonary Disease (COPD) Introduction VisionGate’s LuCED® test for lung cancer measures 934 features in each cell imaged in 3D by the Cell- CT™. Sensitivity and specificity, both exceeding 90%, have been reported (Wilbur, et. al., Cancer Cytopathology, ...